Indian Pharma Sector India's pharmaceutical sector is gaining its position as a global leader

Indian Pharma Sector India's pharmaceutical sector is gaining its position as a global leader, poised to grow from US21.7 currently, to US$ 36.7 billion by 2015. A PricewaterhouseCoopers (PwC) report says it could touch US$ 74 billion by 2020. This is in league with Indian Government's Pharma Vision 2020 which aims at making India a global leader in end-to-end manufacture by 2020, and is planning to set up US$ 640 million VC to boost drug discovery and strengthen the pharmaceutical sector. The Indian Pharma sector produces 600 Generic brands, 600 therapeutic categories, and manufactures more than 500 different APIs. While Generics continue to dominate the market; patent-protected products are expected to constitute 10 per cent of the pie till 2015. Several multinationals are already set to launch patented drugs across India. The demand for high end drugs in rural India is estimated to grow to US$ 8 million by 2015, wherein 70% of India's populace resides. Efforts are being made to reach chemists and OTC drugs to the rural populace through expanding networks. The clinical trials market was US$ 400 million in 2009 and India is expected to remain a valuable investment hub due to its genetically diverse population and availability of skilled doctors. In field of health insurance, 650 million people are expected get health insurance cover by 2020, painting a rosy picture of the Indian Pharma Industry as a whole.

Treatment For Pediatric Migraine

Propofol May Be An Effective Treatment For Pediatric Migraine.

Medscape (10/2, Lowry) reports that at the American Academy of Pain Management 24th Annual Clinical Meeting, “researchers report[ed] that subanesthetic doses of propofol provide a safe and effective abortive treatment for pediatric migraine.” Investigators found that, “compared with the children who received standard abortive migraine therapy,” those who received “propofol achieved significantly greater reduction in pain scores as measured on a self-reported visual analogue scale (VAS).”

ACRI Students Group Discussion

Students of ACRI participate in group discussion on various topics.

Great News from ACRI India Placement Division

75% of previous batch students have been placed, with highest pay package of 4.5 and 4.0 Lakh PA respectively. Moreover the entire 75% candidates are placed in tier 1, MNC companies only. 25% of the students have been offered more than 4 Interview chances and they are still being assisted. 55% of the current batch has been placed even before the course completion.
http://acriindia.com/placement-reviews/student-reviews

ACRI INDIA Clinical Research Placement news

ACRI Placement is proud to announce that it has already placed up to 50% of its June 2013 students. 
http://acriindia.com/placement-reviews/placement-tieups

ACRI Workshop in news paper

News paper coverage about ACRI India Clinical Research Institute's workshop on 14th September 2013. 

http://acriindia.com

ACRI INDIA Clinical Research Workshop on Advances in Clinical Research and Pharmacovigilance

ACRI India Clinical Research Institute hosts a day-long workshop to educate medical professionals and students on recent advances in Clinical Research and Pharmacovigilance

Bangalore, 14^th September 2013: Bangalore-based ACRI India Clinical Research Institute, today conducted a day-long workshop on “Advances in Clinical Trials and Pharmacovigilance” for medical professionals and students from allied health science and life science. The workshop was inaugurated by  Ms Anuradha Ramachandran, Director, ACRI.

The idea to conduct this workshop was conceived to provide the latest trends seen in clinical research and Pharmacovigilance. The workshop witnessed overwhelming participants which in turn reflects the growing interest among doctors and life science graduates in choosing Clinical Research as new career arena.

The day-long workshop was divided into two sessions chaired by Dr Smita Singh, Head of Academics, ACRI and Dr Nisha Nair, an Industry Expert in PV. The first session was mentored by Dr Singh who took the participants on a tour of clinical research by capturing the various steps involved in a drug development in a presentation. Participants were provided with an introduction to Clinical research, followed by drug discovery procedures, good clinical practices and regulatory requirements for drug approval.

At the second session, Dr Nair focused on the current Indian Pharmacovigilance system, importance of Pharmacovigilance in clinical research and advancement required to gain World-wide credit. The session also highlighted other fundamentals of Pharmacovigilance system, such as science of detection, assessment, understanding and prevention of adverse events, reporting systems for adverse events and narrative writing.

The workshop was successfully concluded by furnishing the participants instructive and informative nuances of clinical research. At the end, certificates were handed over to the participants confirming them as ‘GCP trained’ which enable participants to further apply for Clinical Research profiles in CROs ( Contract Research Organization) with the knowledge acquired during the workshop.

ACRI India Clinical Research: is modeled on the lines of some of the premier Clinical Research Institutes of India. We are dedicated and committed to provide excellent Clinical Research Professionals to the Clinical Research Industries. At ACRI, we offer job oriented courses viz., “PG Diploma in Clinical Research” “Clinical Data Management” & “Clinical SAS Programming”

For more information please visit www.acriindia.com or call us at +91 9741 600 499